Get started
Author

Kirsten N. Verpoort

Observed names: K N Verpoort, K. N. Verpoort, K. Verpoort, Kirsten N Verpoort, Verpoort, Kirsten N
OpenAlex ID: A5111985404
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
2005 · Annette HM van der Helm-van Mil, Kirsten N Verpoort, et al. · Arthritis Research & Therapy · 490
PDF
The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis
2006 · Annette H. M. van der Helm‐van Mil, Kirsten N. Verpoort, et al. · Arthritis & Rheumatism · 361
Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis
2010 · Diane van der Woude, Solbritt Rantapää-Dahlqvist, et al. · Annals of the Rheumatic Diseases · 331
Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response
2006 · K. N. Verpoort, C. M. Jol‐van der Zijde, et al. · Arthritis & Rheumatism · 217
Association of HLA–DR3 with anti–cyclic citrullinated peptide antibody–negative rheumatoid arthritis
2005 · Kirsten N. Verpoort, Floris A. van Gaalen, et al. · Arthritis & Rheumatism · 179
The HLA–DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide
2007 · Annette H. M. van der Helm‐van Mil, Kirsten N. Verpoort, et al. · Arthritis & Rheumatism · 145
The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis
2010 · Klaus P Machold, Robert Landewé, et al. · Annals of the Rheumatic Diseases · 139
Fine specificity of the anti–citrullinated protein antibody response is influenced by the shared epitope alleles
2007 · K. N. Verpoort, K. Cheung, et al. · Arthritis & Rheumatism · 131
Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies
2008 · J. K. de Vries‐Bouwstra, Y. P. M. Goekoop‐Ruiterman, et al. · Arthritis & Rheumatism · 103
The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis
2010 · Diane van der Woude, Silje W Syversen, et al. · Annals of the Rheumatic Diseases · 81
Undifferentiated arthritis--disease course assessed in several inception cohorts.
2004 · K N Verpoort, H van Dongen, et al. · PubMed · 80
Association of smoking with the constitution of the anti–cyclic citrullinated peptide response in the absence of HLA–DRB1 shared epitope alleles
2007 · K. N. Verpoort, E. A. M. Papendrecht‐van der Voort, et al. · Arthritis & Rheumatism · 53
Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis
2008 · K Visser, K N Verpoort, et al. · Annals of the Rheumatic Diseases · 41
Short-Term and Long-Term Outcomes of a Vocational Rehabilitation Program for Patients with Acquired Brain Injury in The Netherlands
2017 · Caroline H. van Dongen, Paulien H. Goossens, et al. · Journal of Occupational Rehabilitation · 18
PDF
Pretherapeutic Drug Testing in Acute Leukemias for Prediction of Individual Prognosis
1990 · B. Lathan, M. von Tettau, et al. · Hämatologie und Bluttransfusion · 16
Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study
2007 · YK Onno Teng, Robert J Verburg, et al. · Arthritis Research & Therapy · 15
PDF
The clinical Significance of serum CD8 antigen levels in adult patients with Hodgkin's disease
1991 · A. Gause, K. Verpoort, et al. · Annals of Oncology · 8
Reply
2008 · K. N. Verpoort, A. Ioan, et al. · Arthritis & Rheumatism · 1
Anti-citrullinated peptide antibodies in rheumatoid arthritis and undifferentiated arthritis
2008 · K. N. Verpoort · Leiden Repository (Leiden University)
PDF
Interferon-α in the Treatment of CML: Comparison of Busulfan versus Hydroxyurea versus Interferon-α
1994 · R. Hehlmann, L. Bergmann, et al. · Beiträge zur Onkologie/Contributions to oncology
Works count: 25
Citation count: 2,409
H-index: 15
I10-index: 16
Year
Topic
Type